Source: Medical Device Network

Selux: Selux Diagnostics secures FDA 510(k) clearance for AST testing NGP System

The in vitro antimicrobial resistance test determines the susceptibility of a bacteria to 14 particular antimicrobial agents. The post Selux Diagnostics secures FDA 510(k) clearance for AST testing NGP System appeared first on Medical Device Network.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Steve Lufkin's photo - CEO of Selux

CEO

Steve Lufkin

CEO Approval Rating

87/100

Read more